Protective strategies to prevent trastuzumab-induced cardiotoxicity Reply

被引：0
|
作者：
Earl, Helena M. [1 ,2 ,3 ]
Hiller, Louise [4 ]
Plummer, Chris [6 ,7 ]
Miles, David [5 ]
Wardley, Andrew M. [9 ,10 ]
Cameron, David A. [8 ]
Dunn, Janet A. [4 ]
机构：
[1] Univ Cambridge, Addenbrookes Hosp, Dept Oncol, Cambridge CB2 0QQ, England
[2] Cambridge Univ Hosp Natl Hlth Serv NHS Fdn Trust, Cambridge Breast Canc Res Unit, Cambridge, England
[3] Cambridge Biomed Res Ctr, NIHR, Cambridge, England
[4] Univ Warwick, Warwick Clin Trials Unit, Coventry, W Midlands, England
[5] Mt Vernon Canc Ctr, Med Oncol, Northwood, Middx, England
[6] Newcastle Upon Tyne Hosp NHS Fdn Trust, Dept Cardiol, Newcastle Upon Tyne, Tyne & Wear, England
[7] Freeman Rd Hosp, Newcastle Upon Tyne, Tyne & Wear, England
[8] Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, Canc Edinburgh Res Ctr, Edinburgh, Midlothian, Scotland
[9] Christie NHS Fdn Trust, NIHR Manchester Clin Res Facil, Res & Dev, Manchester, Lancs, England
[10] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Div Canc Sci, Manchester, Lancs, England
来源：
LANCET | 2020年 / 395卷 / 10223期
关键词：
EVENTS; TRIAL;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：492 / 493
页数：3
相关论文
共 50 条
  • [21] Prevalence of trastuzumab-induced cardiotoxicity in a real-world setting
    Calvillo-Arguelles, O.
    Flores-Diaz, D.
    Gonzalez-Serrano, J-P
    Lopez-Rojas, A.
    Mendoza-Galindo, L.
    Matus-Santos, J-A
    Reynoso-Noveron, N.
    Cabrera-Galeana, P.
    Bargallo-Rochaand, E.
    Arce-Salinas, C.
    CANCER RESEARCH, 2019, 79 (04)
  • [22] Factors for time to trastuzumab-induced cardiotoxicity in breast cancer patients
    Mi Hyung Lee
    Jeong Yee
    Young Ju Kim
    Jin Young Moon
    Joo Hee Kim
    Sandy Jeong Rhie
    Hye Sun Gwak
    Medical Oncology, 2017, 34
  • [23] More predictive markers were identified for trastuzumab-induced cardiotoxicity
    Kadri Altundag
    Medical Oncology, 2018, 35
  • [24] More predictive markers were identified for trastuzumab-induced cardiotoxicity
    Altundag, Kadri
    MEDICAL ONCOLOGY, 2018, 35 (01)
  • [25] Trastuzumab-induced cardiotoxicity in early breast cancer patients: a retrospective study of possible risk and protective factors
    Farolfi, Alberto
    Melegari, Elisabetta
    Aquilina, Michele
    Scarpi, Emanuela
    Ibrahim, Toni
    Maltoni, Roberta
    Sarti, Samanta
    Cecconetto, Lorenzo
    Pietri, Elisabetta
    Ferrario, Cristiano
    Fedeli, Anna
    Faedi, Marina
    Nanni, Oriana
    Frassineti, Giovanni Luca
    Amadori, Dino
    Rocca, Andrea
    HEART, 2013, 99 (09) : 634 - 639
  • [26] Is trastuzumab-induced cardiotoxicity involved in onco-cardiology outcome?
    Teresa Alonso Gordoa
    José Ángel García-Sáenz
    Juan Francisco Rodríguez Moreno
    Francisco José Hernández Pérez
    Eduardo Díaz-Rubio
    Clinical and Translational Oncology, 2011, 13 : 451 - 459
  • [27] Role of autophagy as potential molecular mechanism in trastuzumab-induced cardiotoxicity
    Mohan, Nishant
    Shen, Yi
    Wu, Wen Jin
    CANCER RESEARCH, 2015, 75
  • [28] Factors for time to trastuzumab-induced cardiotoxicity in breast cancer patients
    Lee, Mi Hyung
    Yee, Jeong
    Kim, Young Ju
    Moon, Jin Young
    Kim, Joo Hee
    Rhie, Sandy Jeong
    Gwak, Hye Sun
    MEDICAL ONCOLOGY, 2017, 34 (12)
  • [29] A retrospective study of angiotensin-converting enzyme inhibitors or beta-blockers to prevent trastuzumab-induced cardiotoxicity
    Sun, K.
    Anand, K.
    Manne, S.
    Xu, X.
    Niravath, M.
    Nicolas, J. C.
    Jones, S. L.
    Patel, T. A.
    Geyer, C.
    Chang, J. C.
    Niravath, P.
    ANNALS OF ONCOLOGY, 2020, 31 : S933 - S933
  • [30] Molecular mechanisms of trastuzumab-mediated cardiomyopathy: Implications of autophagy in trastuzumab-induced cardiotoxicity
    Mohan, Nishant
    Shen, Yi
    Wu, Wen J.
    CANCER RESEARCH, 2016, 76
12345